ClinicalTrials.gg
CompletedNCT07910513AV-ENDOUpdated Nov 2, 2026

Effect of Audiovisual Distraction on Dental Anxiety and Heart Rate During Root Canal Treatment

An interventional study of Audiovisual Distraction in Symptomatic Irreversible Pulpitis, Symptomatic Irreversible Pulpitis (SIP) and Symptomatic Irreversible Pulpitis and Post Operative Pain, sponsored by Ramón Miguéns-Vila. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Ramón Miguéns-Vila · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Mar 2026, registered Oct 2026).
Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Dental anxiety is common among patients undergoing root canal treatment and may negatively affect their experience during dental care. Audiovisual distraction, combining visual entertainment with sound delivered through headphones, may help reduce anxiety by redirecting patients' attention away from the dental procedure.

The purpose of this randomized clinical trial was to evaluate whether a ceiling-mounted audiovisual entertainment system could reduce dental anxiety and heart rate during root canal treatment in patients diagnosed with symptomatic irreversible pulpitis.

A total of 100 adult patients were allocated to two groups. Participants in the intervention group received root canal treatment while watching audiovisual entertainment on a ceiling-mounted screen and listening through headphones. Participants in the control group underwent conventional root canal treatment without audiovisual entertainment.

Dental anxiety and heart rate were assessed at four predefined time points during the treatment appointment. The study compared changes in these outcomes between the two groups to determine whether audiovisual distraction could improve the patient experience during endodontic treatment.

Read the detailed description

Background and rationale

Root canal treatment is frequently associated with anxiety, particularly among patients experiencing dental pain. Symptomatic irreversible pulpitis may increase psychological distress before and during treatment. Anxiety can influence patients' perception of dental procedures and may be accompanied by physiological responses, including changes in heart rate.

Non-pharmacological approaches to anxiety management are of interest because they can be incorporated into routine clinical practice without the need for additional medication. Audiovisual distraction is intended to redirect attention away from potentially stressful stimuli associated with dental treatment.

Study objective

The primary objective of this randomized clinical trial was to assess the effect of a ceiling-mounted audiovisual entertainment system on dental anxiety and heart rate during nonsurgical root canal treatment in adult patients with symptomatic irreversible pulpitis.

Study design

This was a two-arm, parallel-group randomized clinical trial involving 100 participants, with 50 allocated to each group.

Participants assigned to the intervention group underwent root canal treatment while viewing audiovisual content on a ceiling-mounted screen and listening through headphones. Participants assigned to the control group received conventional root canal treatment without the audiovisual distraction system.

Study procedures

All participants underwent endodontic treatment according to the clinical protocol established for the study. Dental anxiety was assessed using a patient-reported visual analog scale, and heart rate was recorded as a physiological indicator of anxiety-related responses.

Both variables were evaluated at four predefined assessment points during the treatment appointment, allowing the investigators to examine changes over time and compare the responses of the two study groups.

Clinical relevance

The study was designed to investigate whether audiovisual distraction could be a practical, non-pharmacological adjunct for anxiety management during endodontic treatment. Its findings may help clinicians evaluate the potential usefulness of this approach in routine dental practice.

02

Conditions studied

  • Symptomatic Irreversible Pulpitis
  • Symptomatic Irreversible Pulpitis (SIP)
  • Symptomatic Irreversible Pulpitis and Post Operative Pain
  • Dental Anxiety

Browse trials for

Keywords

  • Audiovisual Distraction
  • Endodontic Treatment
  • Root Canal Treatment
  • Dental Anxiety
  • Heart Rate
  • Non-pharmacological Intervention
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's enrollment of 100 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

This is the only study on the registry with Ramón Miguéns-Vila as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older.
  • Diagnosis of symptomatic irreversible pulpitis in a single tooth requiring nonsurgical root canal treatment.
  • Moderate-to-severe dental pain with a prolonged response to cold testing, consistent with symptomatic irreversible pulpitis.
  • (ASA) physical status I or II.

Exclusion criteria

Exclusion Criteria:

  • Current use of anxiolytic or antidepressant medication.
  • Uncontrolled hypertension.
  • Cardiac arrhythmias.
  • Diagnosed psychiatric disorders.
  • Visual or hearing impairment severe enough to interfere with the use of the audiovisual distraction system.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Audiovisual Distraction Group

    Participants received conventional nonsurgical root canal treatment while watching audiovisual entertainment on a ceiling-mounted screen and listening through headphones. The audiovisual distraction system was used during the treatment appointment to reduce dental anxiety.

    Behavioral: Audiovisual Distraction

  • No intervention
    Conventional Treatment Group

    Participants received conventional nonsurgical root canal treatment without audiovisual entertainment. All other aspects of endodontic treatment followed the same clinical protocol as in the experimental group.

Interventions

  • BehavioralAudiovisual Distraction

    Audiovisual distraction was provided during nonsurgical root canal treatment using a ceiling-mounted screen and headphones. Participants assigned to the experimental group watched audiovisual entertainment while undergoing the dental procedure. The intervention was intended to redirect attention away from treatment-related stimuli and reduce dental anxiety.

06

What researchers measure

Primary outcomes

  1. Change in Dental Anxiety Assessed Using a Visual Analog Scale (VAS)

    Dental anxiety was assessed using a 10-cm visual analog scale (VAS), with higher scores indicating greater anxiety. Assessments were conducted immediately before treatment, immediately after the local anesthetic injection, during active endodontic treatment, and immediately after treatment completion. The assessment obtained immediately after the injection referred to the anxiety experienced during administration of local anesthesia. All assessments took place on the same day, during a single endodontic treatment appointment. Changes in VAS scores over time and the difference between baseline and the final assessment were compared between groups.

    Time frame: Same day, single treatment session: immediately before treatment (baseline); immediately after local anesthetic injection (anxiety experienced during injection); during active endodontic treatment; immediately after treatment completion.

  2. Change in Heart Rate During Root Canal Treatment

    Heart rate was measured in beats per minute (bpm) immediately before treatment, during administration of the local anesthetic injection, during active endodontic treatment, and immediately after treatment completion. All measurements took place on the same day, during a single endodontic treatment appointment. Changes in heart rate over time and the difference between baseline and the final assessment were compared between the audiovisual distraction and control groups.

    Time frame: Same day, single treatment session: immediately before treatment (baseline); during local anesthetic injection; during active endodontic treatment; immediately after treatment completion.

07

Study locations

1 site
  • Clinica EOC+
    Santiago de Compostela, A Coruña 15701, Spain
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available. The study findings will be reported in aggregate form to protect participant confidentiality.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Jun 2026, 3 months.

Of 2,089 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 3 months is below that.

Counting every sponsor, half of 2,102 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 19, 2026
First posted
Nov 2, 2026
StartActual
Mar 16, 2026
Primary completionActual
Jun 30, 2026
CompletionActual
Jun 30, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07910513
Lead sponsor
Ramón Miguéns-Vila
Responsible party
Ramón Miguéns-Vila (Principal Investigator and Associate Professor of Dentistry, University of Santiago de Compostela) — Sponsor-investigator
First posted
Nov 2, 2026
Start date
Mar 16, 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026
Last update
Nov 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion